Attention Deficit Hyperactivity Disorder (ADHD) in Adolescents With Substance Use Disorders (SUD)
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy of osmotic-release methylphenidate
(OROS-MPH) versus placebo for the treatment of ADHD in adolescents with SUD.
Phase:
Phase 3
Details
Lead Sponsor:
University of Cincinnati
Collaborators:
National Institute on Drug Abuse (NIDA) University of Colorado, Denver